Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ellaOne or placebo followed by quick-start Microgynon and ovarian activity
2011-005573-23Phase 4Completed
- Sponsor
- HRA Pharma
- Start
- Jan 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in contraception comparing ellaOne then Microgynon with Placebo then Microgynon (2 arms). Primary endpoint: Ovarian quiescence by Hoogland score. Started Jan 2012; status: completed.
02
Drugs
ulipristalethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2011-005573-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005573-23.